Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1781-1790
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1781
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1781
Figure 1 Cumulative progression-free survival and overall survival.
A: 1-year progression-free survival; B: 1-year overall survival. PFS: Progression-free survival; OS: Overall survival.
- Citation: Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer. World J Gastrointest Oncol 2021; 13(11): 1781-1790
- URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1781.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1781